Inflammation can slow the early development of cancers in a protein-producing gene, said Georgetown University Medical Center researchers and alumni who took part in a five-year study published Nov....
MedStar Georgetown University Hospital began installation of Washington, D.C.’s first superconducting synchrocyclotron proton accelerator, which is used in cancer treatment therapy, in February.
The...
Director of the Drug Discovery Program at the Georgetown Lombardi Comprehensive Cancer Center Milton Brown received the annual Percy L. Julian Award for his work in new drug discovery and testing against...
Beth Peshkin, professor of oncology and senior genetic counselor at Georgetown’s Lombardi Comprehensive Cancer Center, will be teaching a new course titled “Genomics, Precision Medicine and Public...
The Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital embarked on a nationwide clinical trial Sept. 1 that will compare two melanoma drugs.
ECOG-ACRIN Cancer...
The National Cancer Institute renewed the Georgetown Lombardi Comprehensive Cancer Center’s status as Washington, D.C.’s only comprehensive cancer center — a title the center has held for 20 years...
Georgetown's Lombardi Comprehensive Cancer Center announced the launch of a study that examines the effect of chemotherapy on the thoughts and memory of patients on Jan. 31.
Researchers will interview...
